Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), Canada's top recreational cannabis company by market share, reported record results for the fourth quarter and twelve months ending on September 30, 2025. The fourth quarter of 2025 saw gross revenue of $123.3 million, marking a 76% increase year-over-year. All financial figures in this release are in Canadian dollars.